Previous 10 | Next 10 |
Shares of InMode (NASDAQ: INMD) soared on Thursday after the medical device company released preliminary financial results for the third quarter of 2022. The numbers were better than Wall Street anticipated. As a result, InMode stock was up 13% as of 11:45 a.m. ET. InMode habitu...
Originally Posted: 10/13/2022 8:30 AM ET It doesn’t seem to matter if you’re trading penny stocks or stocks over $5, what’s happening in the stock market this week has greatly impacted sentiment on the inflation outlook. Yesterday’s Producer Price Ind...
InMode Expects Record Third Quarter 2022 Revenue of $120.5M-$120.9M, Raising Full-Year 2022 Revenue Guidance to $445M-450M PR Newswire Conference call to be held on Thursday, October 27, 2022 , at 8:30 a.m. Eastern Time YOKNEAM, Israel , Oct. 13, 2022...
Summary Public Service Announcement: INMD will be reporting FQ3'22 earnings by the end of October 2022. Consensus estimates remain cautiously optimistic about its long-term projection for now. However, the recession may lead to short-term destruction of demand for INMD, puttin...
With the S&P 500 index making new lows in 2022, it is crucial investors stay the course and continue adding high-quality businesses to their portfolios -- through dollar-cost averaging, if possible. While everyone's description of a high-quality business varies, three stocks tod...
Eva Longoria Announced as InMode Global Brand Ambassador PR Newswire Partnership to Empower Women and Drive Awareness of InMode's Leading Procedures IRVINE, Calif. , Sept. 29, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global p...
Bear markets are never fun. Downtrodden equity markets are, however, a great time for investors with a long-term mindset to buy stocks. Keeping with this theme, the 2022 bear market has created a slew of attractive buying opportunities. Cosmetic surgery company InMode (NASDAQ: INM...
Summary InMode dedicates to closing the gap between traditional laser treatment and plastic surgery through its ablative aesthetic medical device patents. InMode's unique ecosystem will benefit from the secular demand and long-term outsourced manufacturing contracts. InMode ha...
Summary Return on equity (ROE) may help to reveal profitable firms, but does Wall Street reward the stock prices of these firms? Warren Buffett considers it a positive sign when a company is able to earn above-average returns on equity. Return on equity can be simply stated as...
Summary I called InMode a buy in June before it rallied as much as 58%. We've pulled back a bunch, and I think we likely have a local bottom in place. I am reloading on InMode as I think it's ready for another rally. This past June I posted a bull thesis on medical d...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 06:00:08 ET Matthew Taylor from Jefferies issued a price target of $19.00 for INMD on 2024-07-23 05:00:00. The adjusted price target was set to $19.00. At the time of the announcement, INMD was trading at $17.75. The overall price target consensus is at $34.50...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...